Annual EBITDA:
-$211.22M-$123.53M(-140.88%)Summary
- As of today, SMMT annual EBITDA is -$211.22 million, with the most recent change of -$123.53 million (-140.88%) on December 31, 2024.
- During the last 3 years, SMMT annual EBITDA has fallen by -$106.52 million (-101.74%).
- SMMT annual EBITDA is now -171201.70% below its all-time high of -$123.30 thousand, reached on January 31, 2004.
Performance
SMMT EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBITDA:
-$234.17M+$334.23M(+58.80%)Summary
- As of today, SMMT quarterly EBITDA is -$234.17 million, with the most recent change of +$334.23 million (+58.80%) on September 30, 2025.
- Over the past year, SMMT quarterly EBITDA has dropped by -$176.07 million (-303.09%).
- SMMT quarterly EBITDA is now -773.09% below its all-time high of $34.79 million, reached on July 31, 2018.
Performance
SMMT Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
-$935.17M-$176.07M(-23.20%)Summary
- As of today, SMMT TTM EBITDA is -$935.17 million, with the most recent change of -$176.07 million (-23.20%) on September 30, 2025.
- Over the past year, SMMT TTM EBITDA has dropped by -$753.96 million (-416.06%).
- SMMT TTM EBITDA is now -28713.56% below its all-time high of -$3.25 million, reached on October 31, 2013.
Performance
SMMT TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
SMMT EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -140.9% | -303.1% | -416.1% |
| 3Y3 Years | -101.7% | -979.6% | -904.3% |
| 5Y5 Years | -297.7% | -1075.0% | -1736.3% |
SMMT EBITDA Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -175.1% | at low | -1793.3% | +58.8% | -1355.1% | at low |
| 5Y | 5-Year | -297.7% | at low | -1793.3% | +58.8% | -1736.3% | at low |
| All-Time | All-Time | >-9999.0% | at low | -773.1% | +58.8% | >-9999.0% | at low |
SMMT EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | -$234.17M(+58.8%) | -$935.17M(-23.2%) |
| Jun 2025 | - | -$568.40M(-750.6%) | -$759.10M(-222.4%) |
| Mar 2025 | - | -$66.83M(-1.6%) | -$235.45M(-11.5%) |
| Dec 2024 | -$211.22M(-140.9%) | -$65.78M(-13.2%) | -$211.20M(-16.5%) |
| Sep 2024 | - | -$58.09M(-29.8%) | -$181.21M(-26.5%) |
| Jun 2024 | - | -$44.75M(-5.1%) | -$143.28M(-25.9%) |
| Mar 2024 | - | -$42.58M(-18.9%) | -$113.82M(-29.8%) |
| Dec 2023 | -$87.69M(-14.2%) | -$35.80M(-77.6%) | -$87.70M(-36.5%) |
| Sep 2023 | - | -$20.16M(-31.8%) | -$64.27M(+2.3%) |
| Jun 2023 | - | -$15.30M(+7.0%) | -$65.80M(-0.3%) |
| Mar 2023 | - | -$16.45M(-33.0%) | -$65.62M(+13.1%) |
| Dec 2022 | -$76.79M(+26.7%) | -$12.37M(+43.0%) | -$75.52M(+18.9%) |
| Sep 2022 | - | -$21.69M(-43.5%) | -$93.12M(+2.1%) |
| Jun 2022 | - | -$15.12M(+42.6%) | -$95.09M(+12.9%) |
| Mar 2022 | - | -$26.35M(+12.1%) | -$109.16M(-4.3%) |
| Dec 2021 | -$104.70M(-50.3%) | -$29.96M(-26.6%) | -$104.70M(-16.3%) |
| Sep 2021 | - | -$23.66M(+18.9%) | -$90.00M(-4.3%) |
| Jun 2021 | - | -$29.18M(-33.4%) | -$86.26M(-13.9%) |
| Mar 2021 | - | -$21.89M(-43.4%) | -$75.72M(-14.4%) |
| Dec 2020 | -$69.64M(-31.1%) | - | - |
| Dec 2020 | - | -$15.26M(+23.4%) | -$66.19M(-30.0%) |
| Sep 2020 | - | -$19.93M(-6.9%) | -$50.93M(-64.3%) |
| Jun 2020 | - | -$18.64M(-50.9%) | -$31.00M(-150.9%) |
| Mar 2020 | - | -$12.35M(+18.2%) | -$12.35M(-34.5%) |
| Dec 2019 | -$53.11M(-55.1%) | - | - |
| Jan 2019 | - | -$15.10M(+1.5%) | -$9.19M(+5.6%) |
| Oct 2018 | - | -$15.33M(-144.1%) | -$9.73M(-198.8%) |
| Jul 2018 | - | $34.79M(+356.8%) | -$3.26M(+92.5%) |
| Apr 2018 | - | -$13.55M(+13.4%) | -$43.61M(-17.2%) |
| Jan 2018 | -$34.24M | - | - |
| Jan 2018 | - | -$15.64M(-76.6%) | -$37.19M(-27.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Oct 2017 | - | -$8.86M(-59.2%) | -$29.10M(-7.8%) |
| Jul 2017 | - | -$5.56M(+22.0%) | -$27.00M(+14.6%) |
| Apr 2017 | - | -$7.14M(+5.5%) | -$31.61M(+5.3%) |
| Jan 2017 | -$32.42M(+3.1%) | - | - |
| Jan 2017 | - | -$7.55M(-11.7%) | -$33.36M(+4.5%) |
| Oct 2016 | - | -$6.76M(+33.6%) | -$34.92M(+4.3%) |
| Jul 2016 | - | -$10.17M(-14.4%) | -$36.47M(-9.0%) |
| Apr 2016 | - | -$8.89M(+2.4%) | -$33.47M(-9.4%) |
| Jan 2016 | -$33.46M(-48.9%) | - | - |
| Jan 2016 | - | -$9.11M(-9.6%) | -$30.61M(-12.1%) |
| Oct 2015 | - | -$8.31M(-15.9%) | -$27.30M(-16.6%) |
| Jul 2015 | - | -$7.17M(-18.9%) | -$23.42M(-5.1%) |
| Apr 2015 | - | -$6.03M(-3.9%) | -$22.29M(-6.2%) |
| Jan 2015 | -$22.48M(-101.0%) | - | - |
| Jan 2015 | - | -$5.80M(-31.0%) | -$21.00M(-8.5%) |
| Oct 2014 | - | -$4.43M(+26.6%) | -$19.35M(-6.5%) |
| Jul 2014 | - | -$6.04M(-27.6%) | -$18.17M(-49.7%) |
| Apr 2014 | - | -$4.73M(-13.8%) | -$12.14M(-63.9%) |
| Jan 2014 | -$11.18M(-98.7%) | - | - |
| Jan 2014 | - | -$4.16M(-28.1%) | -$7.40M(-128.1%) |
| Oct 2013 | - | -$3.25M | -$3.25M |
| Jan 2013 | -$5.63M(-25.9%) | - | - |
| Jan 2012 | -$4.47M(+12.6%) | - | - |
| Jan 2011 | -$5.11M(+9.5%) | - | - |
| Jan 2010 | -$5.65M(+72.7%) | - | - |
| Jan 2009 | -$20.71M(+3.7%) | - | - |
| Jan 2008 | -$21.50M(-183.5%) | - | - |
| Jan 2007 | -$7.59M(-152.0%) | - | - |
| Jan 2006 | -$3.01M(-485.8%) | - | - |
| Jan 2005 | -$513.80K(-316.7%) | - | - |
| Jan 2004 | -$123.30K | - | - |
FAQ
- What is Summit Therapeutics Inc. annual EBITDA?
- What is the all-time high annual EBITDA for Summit Therapeutics Inc.?
- What is Summit Therapeutics Inc. annual EBITDA year-on-year change?
- What is Summit Therapeutics Inc. quarterly EBITDA?
- What is the all-time high quarterly EBITDA for Summit Therapeutics Inc.?
- What is Summit Therapeutics Inc. quarterly EBITDA year-on-year change?
- What is Summit Therapeutics Inc. TTM EBITDA?
- What is the all-time high TTM EBITDA for Summit Therapeutics Inc.?
- What is Summit Therapeutics Inc. TTM EBITDA year-on-year change?
What is Summit Therapeutics Inc. annual EBITDA?
The current annual EBITDA of SMMT is -$211.22M
What is the all-time high annual EBITDA for Summit Therapeutics Inc.?
Summit Therapeutics Inc. all-time high annual EBITDA is -$123.30K
What is Summit Therapeutics Inc. annual EBITDA year-on-year change?
Over the past year, SMMT annual EBITDA has changed by -$123.53M (-140.88%)
What is Summit Therapeutics Inc. quarterly EBITDA?
The current quarterly EBITDA of SMMT is -$234.17M
What is the all-time high quarterly EBITDA for Summit Therapeutics Inc.?
Summit Therapeutics Inc. all-time high quarterly EBITDA is $34.79M
What is Summit Therapeutics Inc. quarterly EBITDA year-on-year change?
Over the past year, SMMT quarterly EBITDA has changed by -$176.07M (-303.09%)
What is Summit Therapeutics Inc. TTM EBITDA?
The current TTM EBITDA of SMMT is -$935.17M
What is the all-time high TTM EBITDA for Summit Therapeutics Inc.?
Summit Therapeutics Inc. all-time high TTM EBITDA is -$3.25M
What is Summit Therapeutics Inc. TTM EBITDA year-on-year change?
Over the past year, SMMT TTM EBITDA has changed by -$753.96M (-416.06%)